Format

Send to

Choose Destination
See comment in PubMed Commons below
Transl Res. 2009 Jul;154(1):1-6. doi: 10.1016/j.trsl.2009.03.007. Epub 2009 Apr 22.

Relaxin and its role in the development and treatment of fibrosis.

Author information

1
Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebr., USA. rgbennet@unmc.edu

Abstract

Relaxin, which is a peptide hormone of the insulin superfamily, is involved in the promotion of extracellular matrix remodeling. This property is responsible for many well-known reproductive functions of relaxin. Recent important findings, including the identification of the relaxin receptor and the development of the relaxin-null mouse, have identified new targets and mechanisms for relaxin's actions, which resulted in unprecedented advances in the field. Relaxin has emerged as a natural suppressor of age-related fibrosis in many tissues, which include the skin, lung, kidney, and heart. Furthermore, relaxin has shown efficacy in the prevention and treatment of a variety of models of experimentally induced fibrosis. The intention of this review is to present a summary of recent advances in relaxin research, with a focus on areas of potential translational research on fibrosis in nonreproductive organs.

PMID:
19524867
PMCID:
PMC2697124
DOI:
10.1016/j.trsl.2009.03.007
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Support Center